World Drug Safety Congress Europe Berlin, Germany 12-13 September 2017

Description:
The two day conference will feature a variety of case study presentations covering what's new in drug safety, the recent EMA revisions and guidance documents and a focus on PV processes outside Europe. We will bring together 90+ experts to discuss the key challenges and solutions in drug safety this September at our 11th annual forum.

Key opinion leaders will share their thoughts through presentations, round tables and panel discussions.

We will have a diverse set of specially selected speakers from leading small, medium and big pharma and biotech companies, regulatory agencies, clinicians and many more to help you prepare for the future of drug safety.

Price:
Academic/Public sector package: EUR 650
Pharma/Biotech Package: EUR 1350
Vendor Package: EUR 1750

Speakers: Sue Rees; EU QPPV Executive Director; Global Safety Grunenthal Gmbh, Peter De Veene; Senior VP and Head of Global Drug Safety and Qualified Person for Pharmacovigilance; GSK, Haris Shaikh; Director Safety Evaluation and Risk Management; Medical Director, Berit Nautrup Andersen; QPPV Director and Head of Global Pharmacovigilance Support; Novo Nordisk, Betina Ostergaard Eriksen; Deputy QPPV; Novo Nordisk